Global Exanthema Market Research Report 2023

Report ID: 1993284 | Published Date: Jan 2025 | No. of Page: 81 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Exanthema Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Antibiotic Drugs
        1.2.3 Non-antibiotic Drugs
    1.3 Market by Application
        1.3.1 Global Exanthema Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Rubeola
        1.3.3 Rubella
        1.3.4 Erythema Infectiosum
        1.3.5 Roseola Infantum
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Exanthema Market Perspective (2017-2028)
    2.2 Exanthema Growth Trends by Region
        2.2.1 Exanthema Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Exanthema Historic Market Size by Region (2017-2022)
        2.2.3 Exanthema Forecasted Market Size by Region (2023-2028)
    2.3 Exanthema Market Dynamics
        2.3.1 Exanthema Industry Trends
        2.3.2 Exanthema Market Drivers
        2.3.3 Exanthema Market Challenges
        2.3.4 Exanthema Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Exanthema Players by Revenue
        3.1.1 Global Top Exanthema Players by Revenue (2017-2022)
        3.1.2 Global Exanthema Revenue Market Share by Players (2017-2022)
    3.2 Global Exanthema Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Exanthema Revenue
    3.4 Global Exanthema Market Concentration Ratio
        3.4.1 Global Exanthema Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Exanthema Revenue in 2021
    3.5 Exanthema Key Players Head office and Area Served
    3.6 Key Players Exanthema Product Solution and Service
    3.7 Date of Enter into Exanthema Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Exanthema Breakdown Data by Type
    4.1 Global Exanthema Historic Market Size by Type (2017-2022)
    4.2 Global Exanthema Forecasted Market Size by Type (2023-2028)
5 Exanthema Breakdown Data by Application
    5.1 Global Exanthema Historic Market Size by Application (2017-2022)
    5.2 Global Exanthema Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Exanthema Market Size (2017-2028)
    6.2 North America Exanthema Market Size by Country (2017-2022)
    6.3 North America Exanthema Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Exanthema Market Size (2017-2028)
    7.2 Europe Exanthema Market Size by Country (2017-2022)
    7.3 Europe Exanthema Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Exanthema Market Size (2017-2028)
    8.2 Asia-Pacific Exanthema Market Size by Country (2017-2022)
    8.3 Asia-Pacific Exanthema Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Exanthema Market Size (2017-2028)
    9.2 Latin America Exanthema Market Size by Country (2017-2022)
    9.3 Latin America Exanthema Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Exanthema Market Size (2017-2028)
    10.2 Middle East & Africa Exanthema Market Size by Country (2017-2022)
    10.3 Middle East & Africa Exanthema Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Manus Aktteva Biopharma
        11.1.1 Manus Aktteva Biopharma Company Detail
        11.1.2 Manus Aktteva Biopharma Business Overview
        11.1.3 Manus Aktteva Biopharma Exanthema Introduction
        11.1.4 Manus Aktteva Biopharma Revenue in Exanthema Business (2017-2022)
        11.1.5 Manus Aktteva Biopharma Recent Development
    11.2 Teva Pharmaceutical Industries
        11.2.1 Teva Pharmaceutical Industries Company Detail
        11.2.2 Teva Pharmaceutical Industries Business Overview
        11.2.3 Teva Pharmaceutical Industries Exanthema Introduction
        11.2.4 Teva Pharmaceutical Industries Revenue in Exanthema Business (2017-2022)
        11.2.5 Teva Pharmaceutical Industries Recent Development
    11.3 CIRON Drugs & Pharmaceuticals
        11.3.1 CIRON Drugs & Pharmaceuticals Company Detail
        11.3.2 CIRON Drugs & Pharmaceuticals Business Overview
        11.3.3 CIRON Drugs & Pharmaceuticals Exanthema Introduction
        11.3.4 CIRON Drugs & Pharmaceuticals Revenue in Exanthema Business (2017-2022)
        11.3.5 CIRON Drugs & Pharmaceuticals Recent Development
    11.4 Iol Chemicals and Pharmaceuticals
        11.4.1 Iol Chemicals and Pharmaceuticals Company Detail
        11.4.2 Iol Chemicals and Pharmaceuticals Business Overview
        11.4.3 Iol Chemicals and Pharmaceuticals Exanthema Introduction
        11.4.4 Iol Chemicals and Pharmaceuticals Revenue in Exanthema Business (2017-2022)
        11.4.5 Iol Chemicals and Pharmaceuticals Recent Development
    11.5 Mikart
        11.5.1 Mikart Company Detail
        11.5.2 Mikart Business Overview
        11.5.3 Mikart Exanthema Introduction
        11.5.4 Mikart Revenue in Exanthema Business (2017-2022)
        11.5.5 Mikart Recent Development
    11.6 Ranbaxy Laboratories
        11.6.1 Ranbaxy Laboratories Company Detail
        11.6.2 Ranbaxy Laboratories Business Overview
        11.6.3 Ranbaxy Laboratories Exanthema Introduction
        11.6.4 Ranbaxy Laboratories Revenue in Exanthema Business (2017-2022)
        11.6.5 Ranbaxy Laboratories Recent Development
    11.7 Hikma
        11.7.1 Hikma Company Detail
        11.7.2 Hikma Business Overview
        11.7.3 Hikma Exanthema Introduction
        11.7.4 Hikma Revenue in Exanthema Business (2017-2022)
        11.7.5 Hikma Recent Development
    11.8 Nexgen Pharma
        11.8.1 Nexgen Pharma Company Detail
        11.8.2 Nexgen Pharma Business Overview
        11.8.3 Nexgen Pharma Exanthema Introduction
        11.8.4 Nexgen Pharma Revenue in Exanthema Business (2017-2022)
        11.8.5 Nexgen Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Exanthema Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Antibiotic Drugs
    Table 3. Key Players of Non-antibiotic Drugs
    Table 4. Global Exanthema Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Exanthema Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Exanthema Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Exanthema Market Share by Region (2017-2022)
    Table 8. Global Exanthema Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Exanthema Market Share by Region (2023-2028)
    Table 10. Exanthema Market Trends
    Table 11. Exanthema Market Drivers
    Table 12. Exanthema Market Challenges
    Table 13. Exanthema Market Restraints
    Table 14. Global Exanthema Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Exanthema Market Share by Players (2017-2022)
    Table 16. Global Top Exanthema Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exanthema as of 2021)
    Table 17. Ranking of Global Top Exanthema Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Exanthema Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Exanthema Product Solution and Service
    Table 21. Date of Enter into Exanthema Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Exanthema Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Exanthema Revenue Market Share by Type (2017-2022)
    Table 25. Global Exanthema Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Exanthema Revenue Market Share by Type (2023-2028)
    Table 27. Global Exanthema Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Exanthema Revenue Market Share by Application (2017-2022)
    Table 29. Global Exanthema Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Exanthema Revenue Market Share by Application (2023-2028)
    Table 31. North America Exanthema Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Exanthema Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Exanthema Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Exanthema Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Exanthema Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Exanthema Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Exanthema Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Exanthema Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Exanthema Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Exanthema Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Manus Aktteva Biopharma Company Detail
    Table 42. Manus Aktteva Biopharma Business Overview
    Table 43. Manus Aktteva Biopharma Exanthema Product
    Table 44. Manus Aktteva Biopharma Revenue in Exanthema Business (2017-2022) & (US$ Million)
    Table 45. Manus Aktteva Biopharma Recent Development
    Table 46. Teva Pharmaceutical Industries Company Detail
    Table 47. Teva Pharmaceutical Industries Business Overview
    Table 48. Teva Pharmaceutical Industries Exanthema Product
    Table 49. Teva Pharmaceutical Industries Revenue in Exanthema Business (2017-2022) & (US$ Million)
    Table 50. Teva Pharmaceutical Industries Recent Development
    Table 51. CIRON Drugs & Pharmaceuticals Company Detail
    Table 52. CIRON Drugs & Pharmaceuticals Business Overview
    Table 53. CIRON Drugs & Pharmaceuticals Exanthema Product
    Table 54. CIRON Drugs & Pharmaceuticals Revenue in Exanthema Business (2017-2022) & (US$ Million)
    Table 55. CIRON Drugs & Pharmaceuticals Recent Development
    Table 56. Iol Chemicals and Pharmaceuticals Company Detail
    Table 57. Iol Chemicals and Pharmaceuticals Business Overview
    Table 58. Iol Chemicals and Pharmaceuticals Exanthema Product
    Table 59. Iol Chemicals and Pharmaceuticals Revenue in Exanthema Business (2017-2022) & (US$ Million)
    Table 60. Iol Chemicals and Pharmaceuticals Recent Development
    Table 61. Mikart Company Detail
    Table 62. Mikart Business Overview
    Table 63. Mikart Exanthema Product
    Table 64. Mikart Revenue in Exanthema Business (2017-2022) & (US$ Million)
    Table 65. Mikart Recent Development
    Table 66. Ranbaxy Laboratories Company Detail
    Table 67. Ranbaxy Laboratories Business Overview
    Table 68. Ranbaxy Laboratories Exanthema Product
    Table 69. Ranbaxy Laboratories Revenue in Exanthema Business (2017-2022) & (US$ Million)
    Table 70. Ranbaxy Laboratories Recent Development
    Table 71. Hikma Company Detail
    Table 72. Hikma Business Overview
    Table 73. Hikma Exanthema Product
    Table 74. Hikma Revenue in Exanthema Business (2017-2022) & (US$ Million)
    Table 75. Hikma Recent Development
    Table 76. Nexgen Pharma Company Detail
    Table 77. Nexgen Pharma Business Overview
    Table 78. Nexgen Pharma Exanthema Product
    Table 79. Nexgen Pharma Revenue in Exanthema Business (2017-2022) & (US$ Million)
    Table 80. Nexgen Pharma Recent Development
    Table 81. Research Programs/Design for This Report
    Table 82. Key Data Information from Secondary Sources
    Table 83. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Exanthema Market Share by Type: 2021 VS 2028
    Figure 2. Antibiotic Drugs Features
    Figure 3. Non-antibiotic Drugs Features
    Figure 4. Global Exanthema Market Share by Application in 2021 & 2028
    Figure 5. Rubeola Case Studies
    Figure 6. Rubella Case Studies
    Figure 7. Erythema Infectiosum Case Studies
    Figure 8. Roseola Infantum Case Studies
    Figure 9. Exanthema Report Years Considered
    Figure 10. Global Exanthema Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Exanthema Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Exanthema Market Share by Region: 2021 VS 2028
    Figure 13. Global Exanthema Market Share by Players in 2021
    Figure 14. Global Top Exanthema Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exanthema as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Exanthema Revenue in 2021
    Figure 16. North America Exanthema Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America Exanthema Market Share by Country (2017-2028)
    Figure 18. United States Exanthema Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Exanthema Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Exanthema Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Exanthema Market Share by Country (2017-2028)
    Figure 22. Germany Exanthema Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France Exanthema Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. Exanthema Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy Exanthema Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia Exanthema Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries Exanthema Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Exanthema Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Exanthema Market Share by Region (2017-2028)
    Figure 30. China Exanthema Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan Exanthema Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea Exanthema Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia Exanthema Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India Exanthema Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia Exanthema Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Exanthema Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Exanthema Market Share by Country (2017-2028)
    Figure 38. Mexico Exanthema Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil Exanthema Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Exanthema Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Exanthema Market Share by Country (2017-2028)
    Figure 42. Turkey Exanthema Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia Exanthema Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Manus Aktteva Biopharma Revenue Growth Rate in Exanthema Business (2017-2022)
    Figure 45. Teva Pharmaceutical Industries Revenue Growth Rate in Exanthema Business (2017-2022)
    Figure 46. CIRON Drugs & Pharmaceuticals Revenue Growth Rate in Exanthema Business (2017-2022)
    Figure 47. Iol Chemicals and Pharmaceuticals Revenue Growth Rate in Exanthema Business (2017-2022)
    Figure 48. Mikart Revenue Growth Rate in Exanthema Business (2017-2022)
    Figure 49. Ranbaxy Laboratories Revenue Growth Rate in Exanthema Business (2017-2022)
    Figure 50. Hikma Revenue Growth Rate in Exanthema Business (2017-2022)
    Figure 51. Nexgen Pharma Revenue Growth Rate in Exanthema Business (2017-2022)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
    Figure 54. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Manus Aktteva Biopharma
Teva Pharmaceutical Industries
CIRON Drugs & Pharmaceuticals
Iol Chemicals and Pharmaceuticals
Mikart
Ranbaxy Laboratories
Hikma
Nexgen Pharma
Frequently Asked Questions
Exanthema report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Exanthema report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Exanthema report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports